The B‐Natural study—The outcome of immune tolerance induction therapy in patients with severe haemophilia B-Reference-Cited by-同舟云学术

The B‐Natural study—The outcome of immune tolerance induction therapy in patients with severe haemophilia B

Published:2021-06-12 Issue:5 Volume:27 Page:802-813
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Astermark Jan¹²^ORCID,Holstein Katharina³,Abajas Yasmina L.⁴,Kearney Susan⁵,Croteau Stacy E.⁶^ORCID,Liesner Riana⁷^ORCID,Funding Eva⁸,Kempton Christine L.⁹^ORCID,Acharya Suchitra¹⁰,Lethagen Stefan¹¹,LeBeau Petra¹²,Bowen Joel¹³,Berntorp Erik¹⁴^ORCID,Shapiro Amy D.¹³^ORCID

Affiliation:

1. Department of Translational Medicine Lund University Malmö Sweden

2. Department of Haematology, Oncology and Radiation Physics Skåne University Hospital Malmö Sweden

3. Medical Department, Hemophilia Center University Medical Center Hamburg‐Eppendorf Hamburg Germany

4. Hemophilia and Thrombosis Centre University of North Carolina Chapel Hill North Carolina USA

5. Children's Minnesota Centre for Bleeding and Clotting Disorders Minneapolis Minnesota USA

6. Boston Children's Hospital Boston Haemophilia Centre Boston Massachusetts USA

7. Great Ormond Street Hospital for Children NHS Trust supported by NIHR GOSH, BRC London UK

8. Department of Haematology Institute of Clinical Medicine University Hospital Rigshospitalet University of Copenhagen Copenhagen Denmark

9. Emory University School of Medicine Emory University Atlanta Georgia USA

10. Northwell Haemostasis and Thrombosis Centre New York New York USA

11. Sobi Stockholm Sweden

12. Rho, Inc. Durham North Carolina USA

13. Indiana Haemophilia and Thrombosis Centre Indianapolis Indiana USA

14. Department of Translational Medicine Clinical Coagulation Research Lund University Malmö Sweden

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hae.14357

Reference28 articles.

1. Haemophilia B: Where are we now and what does the future hold?

2. Inhibitors in Hemophilia B

3. Tolerance induction using the Malmö treatment model 1982-1995

4. The North American Immune Tolerance Registry: contributions to the thirty-year experience with immune tolerance therapy

5. Inhibitors in factor IX deficiency a report of the ISTH-SSC international FIX inhibitor registry (1997-2006)

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Haemophilia in the era of novel therapies: Where do inhibitors feature in the new landscape?;Haemophilia;2024-03-27

2. The current challenges faced by people with hemophilia B;European Journal of Haematology;2023-12-11

3. Emerging approaches to induce immune tolerance to therapeutic proteins;Trends in Pharmacological Sciences;2023-12

4. Factor IX administration in the skin primes inhibitor formation and sensitizes hemophilia B mice to systemic factor IX administration;Research and Practice in Thrombosis and Haemostasis;2023-11

5. Angeborene und erworbene Hämophilie;DGIM Innere Medizin;2023